Essential regional control of skin cancers
18 May 2017
Essential regional control of skin cancers
Update in anti-CTLA4 and anti-PD1 treatment in advanced melanoma
Circulating tumour cells in melanoma
Novel high risk genes of melanoma
New insights in Merkel cell biology and treatment
Duration of checkpoint inhibitor therapy
PD1/ CTLA4 : Upfront or sequentially?
Genetic determinants of breast cancer immune phenotypes
Mutational landscapes in pregnant and non-pregnant breast cancer
Deciphering the connection of genetics, immune infiltration and prognosis
Genetic vs immune strategies in breast cancer
Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer